| Literature DB >> 33897177 |
Abstract
The aim of the study was to conduct a systematic review to access the osseointegration between traditional and modified Hydrophilic Titanium Dental Implants for period of 10 years. PUBMed articles were searched from last ten years up to 15/12/2019 from which 24 studies included in this review. This systematic review compiles the data about osseintegration in hydrophilic titanium implants in human trials. It sheds light on the mechanism of integration of hydrophilic surfaces and numeric data to support the purpose of the review. Copyright:Entities:
Keywords: Dental implants; hydrophilic titanium dental implants; osseointegration; systematic review
Year: 2020 PMID: 33897177 PMCID: PMC8051648 DOI: 10.4103/njms.NJMS_44_20
Source DB: PubMed Journal: Natl J Maxillofac Surg ISSN: 0975-5950
List of the studies included into the review
| Authors and year | Type of study | Hydrophilic implant brand | Number of patients | Number of implants | Number of implants lost | Parameters observed | Outcomes |
|---|---|---|---|---|---|---|---|
| Donos | Prospective | SLActive | 9 | 18 | NA | Gene expression | SLActive is pro-osteogenic and pro-angiogenic |
| Lang | Propective | SLActive | 28 | 49 | NA | histomorphometry | SLActive has better osseointegration than others |
| Ivanovski | Prospective | SLActive | 9 | 9 | 0 | Gene ontology | I-kB kinase/NF-kB cascade, early inflammatory changes, osteogenesis-related mechanisms are regulated by TGF-b/BMP |
| Bosshardt | Prospective | SLActive | 28 | 49 | NA | Histomorphometry | New bone formation mediated by old bone |
| Roccuzzo and Wilson 2009[ | Prospective | SLActive | 35 | 35 | Survival rate on early loading | Surface modified hydrophilic implants are suitable for loading at 3 weeks in maxillary molar areas | |
| Iezzi | Retrospective | FRIADENT PLUS | 14 | 14 | NA | Histomorphometry | The efficacy of dental implants is related to biological and biomechanical stability and to the integration between the bone and the implant |
| Hinkle | Prospective | INICELL | 21 | 23 | 0 | Clinical and radiological outcome | Hydrophilic implants loading is a safe and predictable treatment |
| van Eekeren | Prospective | INICELL | 32 | 76 | 0 | ISQ values | Bone level implants had level of ISQ quotient throughout |
| Dolanmaz | Prospective | SLActive | 47 | 47 | 0 | BMP 2, 7 Osteoprotegrin | Cytokines in PICF during early healing of implants reflects the degree of peri-implant inflammation, rather than differences in the implant surfaces |
| Gac and Grunder 2015[ | Retrospective | INICELL | 1063 | 2918 | 30 | Survival rate | Failure was less with hydrophilic implants |
| Hicklin | Prospective | SLActive | 15 | 20 | 0 | ISQ values | Functional occlusal loading possible with hydrophilic implants in posterior mandible |
| Hirota | Prospective | Nobel active | 7 | 49 | 0 | OSI/ISQ | Photo-functionalization accelerated the rate and enhanced of implant stability |
| Degasperi | Retrospective | Neoss active | 49 | 102 | 1 | Survival rate/MBL | Novel hydrophilic implants result in favourable short term outcomes |
| Şener-Yamaner | Prospective | SLActive | 55 | 175 | 3 | MBL | SLActive have successful clinical results |
| Novellino | Prospective | Drive cm acqua, neodent | 21 | 64 | 0 | ISQ | Implants with hydrophilic surfaces integrate faster |
| Makowiecki | Prospective | INICELL/RN SLActive | 15 | 15 | 0 | ISQ/MBL | Insertion of short dental implants with a hydrophilic conditioned surface significantly shows INICELL was better than straumann in osseointegration |
| Cabrera-Domínguez | Prospective | SLActive Roxolid | 29 | 29 | 0 | MBL | Patients with glycemic control exhibit similar outcomes |
| Rosen | Retrospective | PROActive, neoss | 76 | 86 | 3 | ISQ | Treatment with short implants with high survival rate |
| Siqueira | Prospective | Titamax cm acqua, neodent | 11 | 55 | 0 | ISQ | Survival rate similar in both tested implant surfaces |
| Ghazal | Prospective | SLActive roxolid | 47 | 47 | 0 | Survival rate and MBL | Noninferiority of the narrow versus standard diameter Ti-Zr implants |
| Puisys | Prospective | Biohorizons | 180 | 360 | 0 | Removal torque | Photoactivation increases removal torque values |
| Tallarico | Prospective | Hiossen ET III (NH)/(SA) | 14 | 28 | 0 | ISQ | NH viable alternative to SA, as they seem to avoid ISQ drop in remodeling phase |
| Velloso | Prospective | TITAMAX ACQUA | 20 | 20 | 0 | ISQ | Implants with modified surface showed greater ISQ values in the posterior mandible |
| Beena Kumary | Prospective | Adin/chemically modified | 210 | 210 | 0 | ISQ | Implants with chemically modified SAE surfaces showed faster osseointegration |
| Total | 2037 | 4498 | 37 |
NA: Not applicable, ISQ: Implant stability quotient, MBL: Marginal bone loss, TGF-b: Transforming growth factor beta, BMP: Bone morphogenetic protein, PICF: Peri-implant crevicular fluid, NH: New hydrophilic, SAE: Sandblasted and acid-etched, SA: Sandblasted and acid-etched
Studies to evaluate the marginal bone loss around the implants
| Authors and year | Implants placed Number and trade name | Patients in the study | Results Mean MBL |
|---|---|---|---|
| Ghazal | SLA Roxolid - 50 implants | 50 | No implant loss |
| Narrow diameter - 0.27±0.34 mm | |||
| Standard diameter - 0.48±0.67 mm | |||
| Cabrera-Domínguez | Straumann roxolid SLActive - 29 implants | 29 | No implant lost |
| DMG - 1.28±0.38 mm | |||
| CG - 1.11±0.59 mm | |||
| Makowiecki | Spi element INICELL RN SLActive - 30 implants | 30 | No implants lost |
| 0.51±0.37 mm | |||
| Şener-Yamaner | SLActive - 68 implants | 55 | No implant lost |
| 0.53 mm | |||
| Hicklin | Spi element INICELL - 20 implants | 15 | No implant lost |
| 0.97 mm median | |||
| Hinkle | Element rc INICELL - 23 implants | 21 | No implants lost |
| 1.98 mm | |||
| Degasperi | Neoss active - 102 implants | 49 | 1 implant lost |
| 0.7±0.6 mm mean MBL |
MBL: Marginal bone loss, DMG: Diabetes mellitus group, CG: Control group
Descriptive statistics on maximum achieved implant stability quotient values over the last 10 years by hydrophilic implants
| Authors and year | Number of implants | Treatment type | Maximum mean ISQ values |
|---|---|---|---|
| Beena Kumary | 210 | SLA (Group A) | Group A - 86.2 |
| SLA active (Group B) | Group B - 89.4 | ||
| Tallarico | 28 | SLA (Group A) | Group A - 78.1±5.1 |
| SLA with bioresorbable apetite nanocoating (Group B) | Group B - 79.2±3.9 | ||
| Velloso | 20 | SLA (Group A) | Group A - 61±7.2 |
| SLA active (Group B) | Group B - 67.1±5.9 | ||
| Siqueira | 55 | SLA (Group 1) | Group 1 - 69.2 |
| Hydrophilic (Group 2) | Group 2 - 69.2 | ||
| Rosen | 86 | Hydrophilic electrowetted surface | 73.3±4.4 |
| Novellino | 64 | SLA (Group A) | Group A - 81 |
| SLA active (Group B) | Group B - 82.5 | ||
| Hicklin | 20 | Hydrophilic surface | 85±5 |
| Hirota | 49 | Untreated (Group 1) | Group 1 - 65.6±5.5 |
| Photo-functionalized (Group 2) | Group 2 - 69.2±7 | ||
| Van Eekeren | 76 | Hydrophilic surface | 86 |
| Degasperi | 102 | Electrowetted hydrophilic surface | 73.6±7.2 |
ISQ: Implant stability quotient